They are going ok without SAMR This approval will only give it uplift. Not achieving it will not lower Chinese revenue. We are just caught up here with shorters and BKL was a handy opportunity for them to push it lower. Nothing to see here otherwise IMO
BAL Price at posting:
$8.30 Sentiment: Buy Disclosure: Not Held
This approval will only give it uplift. Not achieving it will not lower Chinese revenue. We are just caught up here with shorters and BKL was a handy opportunity for them to push it lower. Nothing to see here otherwise IMO
